Sanofi Wins Dogfight for Merial

Sanofi-Aventis SA will acquire the remaining 50% of the animal-health business Merial from Merck & Co, according to Bloomberg. Global animal drug sales - mostly livestock but also pets - were estimated to grow 7.2% to $19.2 billion in 2008 by Vetnosis Ltd.